Skip to main content
. Author manuscript; available in PMC: 2021 Apr 19.
Published in final edited form as: Ann Surg Oncol. 2018 Jul 3;25(9):2535–2540. doi: 10.1245/s10434-018-6559-6

TABLE 2.

Prognostic factors associated with disease-specific survival (multivariate analysis)

Variable HR (95% CI) p value
Age at diagnosis (year)
 < 45 Reference
 45–59 0.46 (0.07–3.26) 0.439
 60–69 0.70 (0.10–4.87) 0.721
 70–79 1.39 (0.15–13.07) 0.772
 80+ 0 (0–1.77e170) 0.967
Race
 White Reference
 Black 0.90 (0.16–4.85) 0.906
 Other 0.72 (0.06–8.95) 0.797
Tumor size (cm)
 < 3 Reference
 ≥3 5.60 (1.50–21.20) 0.012
Lymph nodes
 Negative Reference
 Positive 19.86 (2.01–196.71) 0.307
Extent of disease
 Local disease Reference
 Regional disease 1.54 (0.32–7.38) 0.588
 Metastatic disease 104.45 (9.89–1103) 0.0001
Surgery
 No Reference
 Yes 0.72 (0.17–3.01) 0.962
Extent of resection
 Parathyroidectomy Reference
 En bloc resection 0.72 (0.17–3.01) 0.648
 Unknown 2.04 (0.21–19.74) 0.539
Radiation
 No Reference
 Yes 1.59 (0.44–5.85) 0.848
Grade
 Well-differentiated Reference
 Moderately differentiated 6.23 (0.21–183.28) 0.289
 Poorly differentiated 4.40 (0.22–89.79) 0.335
 Undifferentiated 10.53 (0.34–325.84) 0.179